Evidence map›Paper›PMID 26075615›Full record

ArticlePloS one2015

Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study.

Jamshid Gadoev, Damin Asadov, Mirzagolib Tillashaykhov, Katie Tayler-Smith, Petros Isaakidis, Andrei Dadu, Pierpaolo de Colombani, Sven Gudmund Hinderaker, Nargiza Parpieva, Dilrabo Ulmasova and 7 more

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Tuberculosis Treatment Outcome and Predictors in Africa: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2021
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Operational Research to Inform Programmatic Approaches to the Management of Tuberculosis in Uzbekistan.International journal of environmental research and public health · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jamshid GadoevWorld Health Organization country office in Tashkent, Tashkent, Uzbekistan.
Damin AsadovState Post Graduate Institute of Medical Education, Tashkent, Uzbekistan.
Mirzagolib TillashaykhovRepublican Specialized TB center, Tashkent, Uzbekistan.
Katie Tayler-SmithMedecins Sans Frontieres (MSF), Operational Center Brussels, Operational Research Unit, MSF-Luxembourg, Luxembourg, Luxembourg.
Petros IsaakidisMedecins Sans Frontieres (MSF), Operational Center Brussels, Operational Research Unit, MSF-Luxembourg, Luxembourg, Luxembourg.
Andrei DaduWHO Regional Office for Europe, TBM department, Copenhagen, Denmark.
Pierpaolo de ColombaniWHO Regional Office for Europe, TBM department, Copenhagen, Denmark.
Sven Gudmund HinderakerCentre for International Health, University of Bergen, Bergen, Norway.
Nargiza ParpievaTashkent Medical Academy, Tashkent, Uzbekistan.
Dilrabo UlmasovaWorld Health Organization country office in Tashkent, Tashkent, Uzbekistan.
Avazbek JalolovRepublican DOTS center, Tashkent, Uzbekistan.
Atadjan HamraevNukus branch of Tashkent State Pediatric Institute, Nukus, Karakalpakstan.
Engy AliMedecins Sans Frontieres (MSF), Operational Center Brussels, Operational Research Unit, MSF-Luxembourg, Luxembourg, Luxembourg.
Martin van den BoomWHO Regional Office for Europe, TBM department, Copenhagen, Denmark.
Asmus HammerichWorld Health Organization country office in Tashkent, Tashkent, Uzbekistan.
Ogtay GozalovWorld Health Organization country office in Tashkent, Tashkent, Uzbekistan.
Masoud DaraWHO Regional Office for Europe, TBM department, Copenhagen, Denmark.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundTB is one of the main health priorities in Uzbekistan and relatively high rates of unfavorable treatment outcomes have recently been reported. This requires closer analysis to explain the reasons and recommend interventions to improve the situation. Thus, by using countrywide data this study sought to determine trends in unfavorable outcomes (lost-to-follow-ups, deaths and treatment failures) and describe their associations with socio-demographic and clinical factors.

methodA countrywide retrospective cohort study of all new and previously treated TB patients registered in the National Tuberculosis programme between January 2006 and December 2010.

resultsAmong 107,380 registered patients, 67% were adults, with smaller proportions of children (10%), adolescents (4%) and elderly patients (19%). Sixty per cent were male, 66% lived in rural areas, 1% were HIV-infected and 1% had a history of imprisonment. Pulmonary TB (PTB) was present in 77%, of which 43% were smear-positive and 53% were smear-negative. Overall, 83% of patients were successfully treated, 6% died, 6% were lost-to-follow-up, 3% failed treatment and 2% transferred out. Factors associated with death included being above 55 years of age, HIV-positive, sputum smear positive, previously treated, jobless and living in certain provinces. Factors associated with lost-to-follow-up were being male, previously treated, jobless, living in an urban area, and living in certain provinces. Having smear-positive PTB, being an adolescent, being urban population, being HIV-negative, previously treated, jobless and residing in particular provinces were associated with treatment failure.

conclusionOverall, 83% treatment success rate was achieved. However, our study findings highlight the need to improve TB services for certain vulnerable groups and in specific areas of the country. They also emphasize the need to develop unified monitoring and evaluation tools for drug-susceptible and drug-resistant TB, and call for better TB surveillance and coordination between provinces and neighbouring countries.

Indexed as

AdolescentAdultAgedAntitubercular AgentsCohort StudiesCoinfectionFemaleHIV InfectionsHumansMaleMiddle AgedOdds RatioPopulation SurveillanceRegistriesRisk FactorsTreatment FailureAntitubercular Agents

Identifiers

PMID26075615
PMCPMC4467982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.